High Note Wealth’s ResMed RMD Stock Holding History

High Note Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.87K	Buy	25 +23	+1,150%	+$4.77K	﹤0.01%	608
2026 Q1	$449	Sell	2 -1	-33%	-$249	﹤0.01%	898
2025 Q4	$723	Buy	+3	New	+$767	﹤0.01%	833

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

High Note Wealth's RMD Position: Q2 2026 in Review

High Note Wealth increased its ResMed (RMD) stake by 1,150% in Q2 2026, buying an estimated $4.77K and bringing the position to 25 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

High Note Wealth first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

High Note Wealth held 25 shares of ResMed worth $4.87K as of Q2 2026.
High Note Wealth bought 23 ResMed shares in Q2 2026, an estimated $4.77K.
ResMed made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #608 holding.
High Note Wealth first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.